Cellosaurus logo
expasy logo

Cellosaurus NOS2AR (CVCL_RN33)

[Text][XML][JSON]
Cell line name NOS2AR
Accession CVCL_RN33
Resource Identification Initiative To cite this cell line use: NOS2AR (RRID:CVCL_RN33)
Comments Population: Japanese.
Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
Disease Ovarian serous cystadenocarcinoma (NCIt: C7978)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_T747 (NOS2)
Sex of cell Female
Age at sampling Age unspecified
Category Cancer cell line
Publications

PubMed=8097673
Osamu Maeda, Motomu Terasawa, Tomohiko Ishikawa, Hidenori Oguchi, Kimio Mizuno, Michiyasu Kawai, Fumitaka Kikkawa, Yutaka Tomoda, Hiroyoshi Hidaka;
A newly synthesized bifunctional inhibitor, W-77, enhances adriamycin activity against human ovarian carcinoma cells.
Cancer Res. 53:2051-2056(1993)

PubMed=8978593; DOI=10.1159/000227661
Yasunori Wakahara, Akihiro Nawa, Tomomitsu Okamoto, Akemi Hayakawa, Fumitaka Kikkawa, Nobuhiko Suganama, Fumiyo Wakahara, Yutaka Tomoda;
Combination effect of anti-Fas antibody and chemotherapeutic drugs in ovarian cancer cells in vitro.
Oncology 54:48-54(1997)

Cross-references
Encyclopedic resources Wikidata; Q54930917
Entry history
Entry creation05-Mar-2018
Last entry update19-Dec-2024
Version number5